About
GRIP Molecular develops a CRISPR protease-based molecular diagnostic platform that rapidly and accurately detects pathogens including bacteria, viruses, and fungi in point-of-care and point-of-need settings using lateral flow and other readout formats.
Explore GRIP Molecular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.